At its Dallas Design District grand opening, Koya Medical marked the official move of its…
Arboretum_JDJuly 1, 2025
Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through…
Arboretum_JDSeptember 4, 2024
Koya Medical recently announced topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective…
Arboretum_JDMarch 6, 2024
Koya Medical Raises New Capital with OrbiMed to Support Growth
OrbiMed, a leading healthcare investment firm and Koya Medical, a healthcare company with a mission…
Arboretum_JDNovember 15, 2023
Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Arboretum_JDOctober 4, 2022
Koya Medical Launches Dayspring® Lower Extremity Active Compression Treatments for Lymphedema and Venous Disorders
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Arboretum_JDApril 14, 2022
Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Casey FrushourFebruary 3, 2022
Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression
Interim clinical trial data presented at American Vein and Lymphatic Society Annual Congress demonstrate patient…
Arboretum_JDOctober 11, 2021
Koya Medical Receives FDA Clearance for Dayspring Lite
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Arboretum_JDSeptember 29, 2021
